⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMRN News
BioMarin Pharmaceuticals Inc
Gene Therapy Remains Top-of-Mind in Hemophilia Despite Recent Market Contraction, as Physicians and Patients Raise the Bar for Success
globenewswire.com
PFE
BMRN
CSL
Gene Therapy Remains Top-of-Mind in Hemophilia Despite Recent Market Contraction, as Physicians and Patients Raise the Bar for Success
globenewswire.com
PFE
BMRN
BioMarin to Participate at the Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026, at 8:00AM ET in Boston
prnewswire.com
BMRN
Form 8-K
sec.gov
BMRN
BioMarin Reports Second Quarter 2026 Financial and Operating Results
prnewswire.com
BMRN
Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight
globenewswire.com
NVS
BBIO
PTC
BMRN
SAVA
PFE
CAT
TMO
LH
VERI
INCY
GILD
MRK
REGN
JAZZ
CELU
OMER
Global Regenerative Medicine Market is Projected to Cross the USD 160 Billion Mark by 2034 | DelveInsight
globenewswire.com
NVS
BBIO
CSL
BMRN
PFE
LNZA
TMO
MRK
CYN
INCY
GSK
JAZZ
GILD
CELU
OMER
PM360 Announces 2026 Lifetime Achievement Award Honoree, CMO of the Year, and Brand Champions
prnewswire.com
LLY
JNJ
BMY
MRK
REGN
KURA
BMRN
TAK
VRTX
GSK
AZN
AMGN
ABBV
BioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome
prnewswire.com
BMRN
From Chip to Grid to Orbit: Yotta 2026 Launches Full Agenda
globenewswire.com
AMAT
KLAC
LRCX
NVDA
AMD
INTC
MSFT
GOOG
AMZN
DLR
XEL
GE
BE
BMRN
CDNS
CRUS
ETN
IREN
JCI
ON
TT
VRT